Long-term plasmapheresis therapy in the management of focal segmental glomerulosclerosis recurrence after kidney transplantation

The recurrence of primary focal segmental glomerulosclerosis (FSGS) after kidney transplantation (KT) appears in 30% of the recipients. Sometimes it can cause the loss of the allograft. Although many treatments for this condition have been reported, 20%-40% of the affected patients are refractory or presents frequents relapses. In this paper we describe the evolution of three recipients treated with long-term plasmapheresis therapy after a recurrence of FSGS with a bad or incomplete response to other treatments.

Source: Transfusion and Apheresis Science - January 1, 2021 Category: Hematology Authors: Gonzalo Ramirez-Guerrero, Angel M Sevillano Prieto, Fernando Jara-Vilugr ón, Natalia Polanco Fernandez, Esther Gonzalez Monte, Ana Henandez Vicente, Lucia C Rodriguez Gayo, Manuel Praga Terente, Amado Andrés Belmonte Source Type: research